Dr. Melody Ann Denson, MD

Dr. Denson practices at Urology Austin in Austin, Texas.

Dr. Denson's NPI, 1154394997, was assigned on February 10, 2006. Dr. Denson graduated from UNMC in 1996. Dr. Denson holds Texas license M1629.

Dr. Denson's primary practice is Urology Austin, at 15534 Ranch Road 620 N Ste 100 Suite 100, Austin, TX 78717-5277. The practice phone is (512) 231-1444.

Dr. Denson's primary practice is Urology Austin in Austin, Texas. Dr. Denson is also affiliated with St. David's North Austin Medical Center. The medical group on file is Urology Austin. Dmand AI also links Dr. Denson to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denson practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Denson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Denson is board certified in urology by the American Board of Urology. Dmand AI has Dr. Denson's licenses on file in 3 states: Texas, Iowa and North Dakota.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse, urinary endoscopy and urine flow blockage among the conditions Dr. Denson treats.

CMS data shows 21,612 Medicare services from Dr. Denson across 26 procedure codes in 2024, for 1,055 Medicare patients. Medicare paid $356,875 for them.

CMS counts 1,055 Medicare patients who saw Dr. Denson in 2024. The largest group is 65 to 74, with 469 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Denson's median patient age at 70, with 68% women.

In 2024, Dr. Denson wrote 6,379 Medicare Part D claims for 1,361 patients. 72% of them were for generic drugs. CMS names the drug for 6,150 of them, across 51 drugs with 11 or more claims each, at $1,397,932 in total drug cost. In 2023, CMS named 5,680 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Denson for performance year 2024, reported as part of a group. Dr. Denson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Denson as offering telehealth.

Dmand AI links 2 papers to Dr. Denson. Dr. Denson has published most often in J Urol.

CMS Open Payments shows 1,074 general payments to Dr. Denson from 64 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Astellas Pharma US Inc paid the most, $29,305.

Dmand AI lists 1 award for Dr. Denson, most recently CMS Stage 1 2012 in 2011.

Dr. Denson graduated from UNMC in 1996.

Dr. Denson is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.